ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $328,000 | +2.8% | 66,745 | +10.6% | 0.00% | – |
| Q2 2021 | $319,000 | +1776.5% | 60,339 | +1586.4% | 0.00% | – |
| Q1 2021 | $17,000 | +6.2% | 3,578 | -5.3% | 0.00% | – |
| Q4 2020 | $16,000 | +23.1% | 3,778 | +18.7% | 0.00% | – |
| Q3 2020 | $13,000 | +62.5% | 3,183 | -4.0% | 0.00% | – |
| Q2 2020 | $8,000 | -98.2% | 3,315 | -97.9% | 0.00% | – |
| Q1 2020 | $453,000 | -31.8% | 156,854 | -10.6% | 0.00% | – |
| Q4 2019 | $664,000 | -46.9% | 175,513 | -28.2% | 0.00% | – |
| Q3 2019 | $1,250,000 | -17.5% | 244,384 | +0.1% | 0.00% | – |
| Q2 2019 | $1,515,000 | -9.7% | 244,248 | +3.5% | 0.00% | – |
| Q1 2019 | $1,678,000 | -9.8% | 236,000 | +8.3% | 0.00% | – |
| Q4 2018 | $1,861,000 | -13.9% | 217,986 | +101.8% | 0.00% | – |
| Q3 2018 | $2,162,000 | -38.4% | 107,997 | -20.6% | 0.00% | -100.0% |
| Q2 2018 | $3,511,000 | +106.3% | 135,934 | +90.9% | 0.00% | – |
| Q1 2018 | $1,702,000 | -14.3% | 71,201 | +21.5% | 0.00% | – |
| Q4 2017 | $1,986,000 | +56.9% | 58,589 | -2.0% | 0.00% | – |
| Q3 2017 | $1,266,000 | +1658.3% | 59,798 | +1348.9% | 0.00% | – |
| Q2 2017 | $72,000 | -14.3% | 4,127 | -13.5% | 0.00% | – |
| Q1 2017 | $84,000 | +61.5% | 4,772 | +54.6% | 0.00% | – |
| Q4 2016 | $52,000 | +271.4% | 3,087 | +273.7% | 0.00% | – |
| Q3 2016 | $14,000 | -58.8% | 826 | -63.5% | 0.00% | – |
| Q2 2016 | $34,000 | -63.8% | 2,261 | -31.9% | 0.00% | – |
| Q4 2015 | $94,000 | +9300.0% | 3,319 | +9957.6% | 0.00% | – |
| Q2 2015 | $1,000 | – | 33 | +230.0% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 10 | -98.8% | 0.00% | – |
| Q4 2014 | $14,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |